Secondary |
Drug Use For Unknown Indication |
54.9% |
Product Used For Unknown Indication |
19.7% |
Nasopharyngitis |
4.9% |
Off Label Use |
2.8% |
Ear Pain |
2.1% |
Intentional Self-injury |
2.1% |
Influenza |
1.4% |
Rapid Eye Movements Sleep Abnormal |
1.4% |
Sleep Disorder |
1.4% |
Smoking Cessation Therapy |
1.4% |
Substance Use |
1.4% |
Anxiety |
0.7% |
Cough |
0.7% |
Headache |
0.7% |
Motion Sickness |
0.7% |
Multiple Allergies |
0.7% |
Pharyngitis |
0.7% |
Rash |
0.7% |
Schizophrenia |
0.7% |
Sinusitis |
0.7% |
|
Respiratory Arrest |
13.2% |
Drug Toxicity |
10.5% |
Intentional Drug Misuse |
10.5% |
Toxicity To Various Agents |
7.9% |
Completed Suicide |
5.3% |
Convulsion |
5.3% |
Foetal Exposure During Pregnancy |
5.3% |
Respiratory Failure |
5.3% |
White Blood Cell Count Increased |
5.3% |
Wrong Drug Administered |
5.3% |
Agitation |
2.6% |
Blood Folate Decreased |
2.6% |
Confusional State |
2.6% |
Dizziness |
2.6% |
Drug Diversion |
2.6% |
Drug Interaction |
2.6% |
Euphoric Mood |
2.6% |
Hyponatraemia |
2.6% |
Intentional Overdose |
2.6% |
Liver Disorder |
2.6% |
|
Concomitant |
Pain |
10.3% |
Product Used For Unknown Indication |
7.7% |
Smoking Cessation Therapy |
7.7% |
Contraception |
7.3% |
Premenstrual Syndrome |
6.8% |
Nasopharyngitis |
6.4% |
Cough |
5.1% |
Hypertension |
5.1% |
Viral Infection |
5.1% |
Bronchitis |
4.7% |
Acne |
4.3% |
Asthma |
4.3% |
Diabetes Mellitus |
3.8% |
Rash |
3.8% |
Oral Contraception |
3.4% |
Diarrhoea |
3.0% |
Hepatic Neoplasm Malignant |
3.0% |
Sinusitis |
3.0% |
Gastrooesophageal Reflux Disease |
2.6% |
Menstruation Irregular |
2.6% |
|
White Blood Cell Count Increased |
10.3% |
Hyponatraemia |
6.9% |
Nausea |
6.9% |
Respiratory Distress |
6.9% |
Weight Increased |
6.9% |
Injury |
5.2% |
Pain |
5.2% |
Pneumonia |
5.2% |
Pulmonary Embolism |
5.2% |
Urticaria |
5.2% |
Vision Blurred |
5.2% |
Anhedonia |
3.4% |
Death |
3.4% |
Dizziness |
3.4% |
Drug Ineffective |
3.4% |
Gallbladder Disorder |
3.4% |
Hypomagnesaemia |
3.4% |
Insomnia |
3.4% |
Rhabdomyolysis |
3.4% |
Sinusitis |
3.4% |
|
Interacting |
Chronic Myeloid Leukaemia |
37.5% |
Motion Sickness |
25.0% |
Nasopharyngitis |
25.0% |
Drug Use For Unknown Indication |
12.5% |
|
Asthenia |
33.3% |
Drug Interaction |
33.3% |
Nasopharyngitis |
16.7% |
Oedema Peripheral |
16.7% |
|